Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Operating Margin: 2021-2025

Historic Operating Margin for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to 42.30%.

  • Krystal Biotech's Operating Margin rose 1550.00% to 42.30% in Q3 2025 from the same period last year, while for Sep 2025 it was 42.39%, marking a year-over-year increase of 3101.00%. This contributed to the annual value of 22.61% for FY2024, which is 23904.00% up from last year.
  • Krystal Biotech's Operating Margin amounted to 42.30% in Q3 2025, which was up 3.37% from 40.93% recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Operating Margin registered a high of 962.00% during Q1 2021, and its lowest value of -303.80% during Q3 2023.
  • For the 3-year period, Krystal Biotech's Operating Margin averaged around -11.39%, with its median value being 26.80% (2024).
  • Data for Krystal Biotech's Operating Margin shows a peak YoY surged of 33,060bps (in 2024) over the last 5 years.
  • Quarterly analysis of 4 years shows Krystal Biotech's Operating Margin stood at 962.00% in 2021, then reached 7.45% in 2023, then skyrocketed by 3,791bps to 45.35% in 2024, then soared by 1,550bps to 42.30% in 2025.
  • Its last three reported values are 42.30% in Q3 2025, 40.93% for Q2 2025, and 41.02% during Q1 2025.